Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

OPINIONS

 keybanc-maintains-overweight-on-crowdstrike-holdings-lowers-price-target-to-376

Keybanc analyst Eric Heath maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Overweight and lowers the price target from $...

 rtx-enters-agreement-with-subsidiary-of-engie-north-america-that-will-provide-100-renewable-electricity-to-12-of-its-texas-facilities

The agreement with ENGIE Resources LLC, which runs through 2033, will begin with six RTX locations in Texas in 2024 and expand ...

 calliditas-therapeutics-presents-additional-data-analyses-from-phase-3-neflgard-trial-of-nefecon-in-primary-iga-nephropathy-at-isn-world-congress-of-nephrology-2024

Richard Philipson, Chief Medical Officer of Calliditas, said, "These additional data further reinforce the impact of Nefeco...

 mediaco-acquires-estrella-medias-content-and-digital-operations

MediaCo Holding Inc. (NASDAQ:MDIA) ("MediaCo") today announced that it has acquired all of Estrella Media's network...

 keybanc-maintains-overweight-on-mongodb-lowers-price-target-to-440

Keybanc analyst Michael Turits maintains MongoDB (NASDAQ:MDB) with a Overweight and lowers the price target from $490 to $440.

 smithnephew-announces-new-evidence-supporting-allevyn-life-foam-dressings-role-in-pressure-injury-prevention

The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding p...

 benitec-biopharma-reports-oversubscribed-private-placement-financing-of-40m

Benitec Biopharma announced a $40.0 million private investment in public equity (PIPE) financing from the sale of 5.749 million...

 chemomab-reports-new-peer-reviewed-publication-reinforcing-the-clinical-association-of-its-ccl24-target-with-disease-severity-and-mortality-in-systemic-sclerosis

Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), ...

Core News & Articles

Anticipated conventional throughput of 64,000 barrels per day (bpd) exceeding guidance of 60,000 to 63,000 bpd due to stronge...

 iridium-communications-reiterated-fy24-service-revenue-growth-of-4-6-oebitda-of-460m-470m

2024 Outlook and Longer-Term Outlook The Company reiterated its full-year 2024 outlook: Total service revenue growth betwee...

 keybanc-maintains-overweight-on-palo-alto-networks-lowers-price-target-to-355

Keybanc analyst Michael Turits maintains Palo Alto Networks (NASDAQ:PANW) with a Overweight and lowers the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist